New Observations on Saxagliptin

31 mins ago - 

Benjamin Scirica discusses his study group’s new analysis of data from the SAVOR-TIMI 53 randomized, placebo-controlled trial of saxagliptin in patients with type 2 diabetes.

How to Ace Your Fellowship Interview

43 mins ago - 

The following compilation of fellowship interview tips was originally published on Twitter between August 15th and 18th by Ethan Weiss, a cardiologist with 13 years of experience interviewing fellowship applicants. Matthew Pirotte also supplied this helpful graph categorizing potential applicants. 1. Prepare like you are interviewing for a job. You are. Know who you are meeting…

Race and Ethnicity Do Not Affect the Benefits of Device Therapy in Heart Failure

11 Sep 2014 - 

Boback Ziaeian discusses his observational study exploring the benefits of guideline-recommended cardiac resynchronization therapy and ICD therapy in heart failure patients, according to race and ethnicity.

11 Sep CardioExchange Editors, Staff wrote a post
Avatar of CardioExchange Editors, Staff

Is This Trial Ethical?

Does the need for a new placebo-controlled trial of epinephrine in cardiac arrest justify questionable consent procedures?

8 Sep Harsh Golwala, MD wrote a post
Avatar of Harsh
2

Anteroseptal MI and Left-Main Dissection in a Pregnant Woman

Harsh Golwala presents our latest case: A 25-year-old woman, 32 weeks pregnant, presents with sudden-onset chest pain. How do you proceed?

8 Sep Richard Lehman, BM, BCh, MRCGP wrote a post
Avatar of Richard Lehman, BM, BCh, MRCGP
1

Selections from Richard Lehman’s Literature Review: September 8th

This week’s topics include the PARADIGM-HF trial, sham controls in medical-device trials, the efficacy of β blockers in patients with heart failure and atrial fibrillation, and more.

5 Sep CardioExchange Editors, Staff wrote a post
Avatar of CardioExchange Editors, Staff
13

Perspectives on PARADIGM-HF

The Editors present a distillation of reader comments on a popular post.

3 Sep CardioExchange Editors, Staff wrote a post
Avatar of CardioExchange Editors, Staff
5

FAME 2 at 2 Years: Better with Time?

The CardioExchange editors ask whether the 2-year findings from FAME 2 are more compelling than the 7-month findings.

1 Sep Vinay Prasad, MD MPH wrote a post
Avatar of Vinay
6

Let’s Take a Close Look at PARADIGM-HF

Vinay Prasad explores three reasons why clinicians should have reservations about the findings from PARADIGM-HF.

1 Sep Richard Lehman, BM, BCh, MRCGP wrote a post
Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: September 1st

This week’s topics include aortic valve stenosis, presenting the benefits of PCI to patients, and more.